TSH Biopharm (ROCO:8432) Ending Cash Position : NT$542.1 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Ending Cash Position?

TSH Biopharm's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$542.1 Mil.

TSH Biopharm's quarterly Ending Cash Position increased from Sep. 2023 (NT$517.7 Mil) to Dec. 2023 (NT$576.6 Mil) but then declined from Dec. 2023 (NT$576.6 Mil) to Mar. 2024 (NT$542.1 Mil).

TSH Biopharm's annual Ending Cash Position increased from Dec. 2021 (NT$381.9 Mil) to Dec. 2022 (NT$488.9 Mil) and increased from Dec. 2022 (NT$488.9 Mil) to Dec. 2023 (NT$576.6 Mil).

TSH Biopharm Ending Cash Position Historical Data

The historical data trend for TSH Biopharm's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Ending Cash Position Chart

TSH Biopharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

224.21

396.70

381.89

488.90

576.59

TSH Biopharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															450.42	583.84	517.72	576.59	542.15

TSH Biopharm Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TSH Biopharm's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	488.904	+	87.681
	=	576.6

TSH Biopharm's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	576.585	+	-34.436
	=	542.1

TSH Biopharm Ending Cash Position Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

TSH Biopharm (ROCO:8432) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115

Website

https://www.tshbiopharm.com

TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically.

TSH Biopharm (ROCO:8432) Headlines

No Headlines